Pharmaceuticals News and Research

RSS

Neuren presents phase 2 clinical trial strategy for NNZ-2566

Neuren Pharmaceuticals has announced that Mr Larry Glass, Executive Vice President and head of Neuren’s US operations, has been invited by the US Army to present Neuren’s clinical trial strategy for NNZ-2566 at the Advanced Technology Applications for Combat Casualty Care (ATACCC) conference.

14 Aug 2006

We need to put the power of HIV prevention in the hands of women

Bill and Melinda Gates has called upon world leaders to "put the power to prevent HIV in the hands of women" by accelerating the search for microbicides and other new HIV prevention tools.

14 Aug 2006

FDA approves generic version of Effexor (venlafaxine)

The U.S. Food and Drug Administration has approved the first generic version of Effexor (venlafaxine), an important step in the agency's effort to increase the availability of lower-cost generic medications.

9 Aug 2006

Oxy-Q may help prevent colon cancer

A pilot clinical trial demonstrates that Oxy-Q, a proprietary pill by Farr Laboratories, LLC that combines the active components of turmeric and onions, reduces both the size and number of precancerous colon polyps.

8 Aug 2006

Atp7a determines a hierarchy of copper metabolism essential for notochord development

A new study reveals the timing of developmental events that critically depend on copper. While copper deficiency is rare in humans, the findings suggest that suboptimal copper metabolism might contribute to birth defects, according to the researchers.

8 Aug 2006

Metal-organic crystals with large pores store drugs and release them over time

A French–Spanish research team has now developed a new type of carrier that can take on a particularly large "load" of medication and then release it in a controlled fashion: metal–organic frameworks with large cavities.

7 Aug 2006

Experimental drug trial victim has cancer

One of the men who suffered severe reactions to an experimental drug during a drug trial in London, UK, says he now has cancer.

6 Aug 2006

Leukemia gene changes genetic packaging

A signaling system involved in many forms of leukemia and lymphoma is more powerful than scientists have thought, exerting control over our genes by affecting whole swaths of chromosomes in global fashion.

6 Aug 2006

Turning the immune system against cancer

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.

4 Aug 2006

Plan B or not to be: that is the question!

The Food and Drug Administration (FDA) in the U.S., meets early next week with the manufacturer of the controversial contraceptive Plan B, in an attempt to resolve the issue of the morning-after contraceptive.

3 Aug 2006

Timing of FDA Plan B announcement questioned

The Center for Reproductive Rights issued the following statement from Nancy Northup, president of the Center for Reproductive Rights, in response to the FDA announcement regarding Plan B.

2 Aug 2006

SRU Biosystems OK'd to conduct business

SRU Biosystems announces the United States District Court for the District of Delaware has resolved in SRU's favor a dispute over the content and scope of a permanent injunction order sought by Corning.

2 Aug 2006

Practical advice and individualized attention can help people with HIV stick to a consistent drug regimen

The studies were too different to combine results, but the review team found that the most successful programs emphasized "practical medicine management," one-on-one attention or a 12-week or longer duration.

2 Aug 2006

New way to assess pandemic potential of influenza viruses

Study provides first assessment of the risk of an H5N1 pandemic strain emerging from the combining of avian and human influenza viruses.

1 Aug 2006

FDA does an about turn on Plan B contraceptive pills

After years of dilly dallying over it's stand on over-the-counter sales of the "morning-after" contraceptive officials at the U.S. Food and Drug Administration (FDA) suddenly appear to be doing an about turn.

31 Jul 2006

US patent granted for 4SC's clinical Project

The Munich-based drug discovery and development company 4SC AG has been informed by the US Patent and Trademark Office (PTO) that the office has granted the patent with the US patent number 7,071,355.

27 Jul 2006

Promising therapy for Lou Gehrig's disease delivers antisense drug directly to nervous system

Researchers have designed and tested a molecular therapy in animals that they hope will be a major development in the fight to treat amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.

27 Jul 2006

New bird flu vaccine has 80% protection rate

According to the manufacturer the latest bird flu vaccine is more than 80% effective in protecting people against the virus.

26 Jul 2006

Mylan granted U.S. patent for transdermal product

Mylan Laboratories has announced that U.S. Patent No. 7,070,808 was issued to its subsidiary, Mylan Technologies Inc. (MTI), on July 4, 2006.

26 Jul 2006

High rates of off-label prescriptions for antidepressant, anticonvulsant and antipsychotic drugs

A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.

26 Jul 2006